Stocktwits Top 25 – Week 28 📈

Good afternoon everyone and welcome back to the Stocktwits Top 25 Newsletter for Week #28, 2020. 

The Stocktwits Top 25 reports the top 25 performing stocks in the S&P 500, Nasdaq 100, and Russell 2000 year to date (YTD) and tracks their performances over time. 

Here are your Stocktwits Top 25 Lists for Week #28:

ST Top 25 S&P 500

Twenty-four of the twenty-five Stocktwits Top 25 S&P 500 names powered higher. 

#1 Dexcom rose 8% and kept the top spot. NVIDIA and Amazon both jumped two spots this week bringing $NVDA to #2 and $AMZN to #3.

Netflix traded up 15% moving up 5 spots from #9 to #4. Msci Inc gained 8.41% climbing from #21 to #14.

Regeneron Pharma was this only biggest loser. It lost only 0.26% but dropped 4 spots from #2 to #6.

$FTNT made its way back onto the ST Top 25 S&P List with a respectable +5% week. 

Here’s the ST Top 25 List for the S&P 500 for Week #28:

The Stocktwits Momentum Meter calculates the average weekly performance of the top 25 stocks and reflects how the top stocks are performing week to week relative to the broader index.

The ST Top 25 S&P 500 Momentum Meter rose 4.42% while the S&P 500 Index only gained 1.76%. The differential shows that the ST Top 25 S&P 500 List outperformed the broader index with steeze.

The Big Cap Nasdaq 100

The Nasdaq 100 closed at another weekly all-time high. 

Tesla rallied ~28% after gaining 27% the prior week. WTF! Elon Musk is now richer than Warren Buffett.

$NTES broke out of another short consolidation and rose 12% this week. More on this one below.

The top 3 stocks in the Nasdaq 100 have all hit triple digit returns for 2020! God bless the internet.

$REGN and $BMRN were this week’s only losers, both biotechs.

The ST Top 25 Nasdaq 100 Momentum Meter gained 5.91% and topped the Nasdaq 100’s 4.01% gain. The 1.90% differential suggests that the top stocks traded slightly better than the full index. 

Small-Cap Russell 2000

The top stocks in the Russell were rockin’ this week. The ST Top 25 R2K list has been on a colossal win streak the last four weeks with gains of 18.68%, 11%, 7.48, and now 13.06%. 

Novavax kept the #1 spot. $NVAX cracked the big 2k 🎉, it’s now up 2,270% YTD. If you’ve been holding since December 31 – you got a 22 bagger! Lord almighty.

Livongo and both soared 45% for the week. $LVGO moved up 7 spots from #12 to #5 and $OSTK moved up one from #4 to #3.

3 Freshmen names entered the list in Week #28. Twist Bioscience was the standout blasting 18.52%.

Celsius Holdings is another Freshman name, entering the list at #20 after gaining 16%. 💥 

Here’s the ST Top 25 List for the Russell 2000 for Week #28:

The Russell 2000 Index fell 0.64% last week while the ST Top 25 Russell 2000 Momentum Meter jumped 13.06%. 

That’s a 13.7% differential in favor of the ST Top 25 R2K. This marks 4 weeks that the top stocks in the Russell 2000 have outperformed handily. Winners win.

The difference between the underperforming broad Russell 2000 Index and the top stocks in the index continues to be a profound one. It’s one of the money 2020 trends that’s been hidden from view unless you’re a regular reader 😉


The ST Top 25 Top Dawg of the Week for Week #28, 2020 is Netflix. 

This beast gained 15% on the week and moved up 5 spots to #4 on the ST Top 25 S&P 500 List. 

Netflix is up 69% YTD and, suddenly, has a shot at the year-end #1 spot. Netflix is benefiting from multiple trends – what a sweet spot play.

First, $NFLX is a classic COVID stock and beneficiary of the nationwide quarantine. Folks are nesting and they watch $NFLX. Simple.

Second, $NFLX runs on a subscription model. Subscriptions are having a moment as we see everyone from Amazon Prime to the monster SaaS plays like Twilio and Zoom. How long will it last…? Who knows 🤷‍♂️

Third – momentum is so in. It’s a real thing (look it up) and 2020 has been a classic momo environment with a narrowing number of strong stocks getting more attention, more capital, and more gains in a positive feedback loop that will remain hella fun for as long as it lasts.

Finally, $NFLX is executing on all fronts, growing it’s library and customer base relentlessly. Shout out, Reed Hastings! $NFLX CEO and Top Dawg of this week’s Top Dawg.

Check out the YTD chart:

The Winners 📈

△  #2 S&P 500 – NVIDIA edged up 2 spots thanks to a monster +9% week. The stock is closing the gap with $DXCM for the top spot on the ST Top 25 S&P 500 List. Can $NVDA take the #1 spot from $DXCM in Week 29? Place your bets…

The semiconductor company saw its market cap top Intel Corp.’s for the first time ever this week.

Out with the old, in with the new? Sick chart:

$NVDA is up 78.33% YTD.

△ #12 N100 – NetEase Inc. was highlighted on last week’s ST Top 25 list of sinners. This week, the stock rebounded like a champ and broke out to new highs. 

The stock gained 12.43% and moved up 3 spots from #15 to #12. It’s now up 58.92% YTD. 💪

△ #5 R2K – Livongo Health’s engine was roarin’ this week. The stock burst to new all-time highs on massive volume. $LVGO gained 45% and is now above Jesse Livermore’s century mark rule at $105.68. 

On Tuesday, the company raised Q2 sales guidance from $73-75 million to $86-87 million and the stock climbed to all-time highs 🧗🏽‍♂️

△  #14 S&P 500 – Msci Inc ran up 7 spots this week, the biggest move on the ST Top 25 S&P 500 list. 

Msci CEO, Henry Fernandez, had this great quote in the company’s last earnings call back in April,

The underpinnings of our business are also predicated on three things: data, huge amounts of data; a lot of analytics, one form or another; and an incredible amount of technology. So as clients work even more remotely and don’t rely on a lot of interpersonal issues, therefore, we should see an uptick on a lot of what we do with our clients.

$MSCI rallied 8.42% last week and is now up 44% YTD.

△  #2 N100 – Tesla Inc, just when y’all thought she ran outta gas… Tesla shares raced another 28% this week and Elon is now worth more than Warren Buffett. As if it mattered. lol.

Also, Tesla has doubled since Elon tweeted the following,

Tesla stock too high imo

Elon would make a great analyst. 🙄😂

The Sinners 📉

There were only 6 stocks that had a weekly loss across all three ST Top 25 lists. All 6 losers happened to be biotechs. Interesting. 🧐

▼ #17 R2K – Kala Pharmaceuticals Inc was this week’s biggest loser, falling 3.79%. 

$KALA is down 25% from its closing high on June 2. Now, the stock is pressing on $10/share and looks a little dicey. Will it hold? Place your bets…

▼ #6 S&P 500 – Regeneron Pharmaceuticals Inc struggled to break even this week while every other name on the ST Top 25 S&P 500 recorded a gain. Ouch, Jim.

$REGN announced the start of its REGN-COV2 Phase 3 Covi-19 prevention trial on Monday. The company states, “A Phase 3 trial will evaluate REGN-COV2’s ability to prevent infection among uninfected people who have had close exposure to a COVID-19 patient (such as the patient’s housemate).”

Despite the losing week, $REGN is still up 65% YTD.

If you have any feedback, please hit us at

*NA’s signify that the stock was just added to the index and so it was not ranked at all in prior weeks.